The recent success of mRNA therapeutics against pathogenic infections has increased
interest in their use for other human diseases including cancer. However, the precise …

Extracellular vesicles (EVs) have shown great potential in drug delivery, disease diagnosis,
and treatment owing to their versatile native features and functions. RNA interference (RNAi) …

Extracellular vesicles (EV)-based delivery of therapeutic mRNAs is challenged by the low
loading efficiency. In this study, we designed a DNA aptamer consisting of two parts: the …

The advent of novel therapeutics in recent years has urged the need for a safe, non-
immunogenic drug delivery vector capable of delivering therapeutic payloads specifically to …

Extracellular vesicles (EVs) are cell-derived, membranous nanoparticles that mediate
intercellular communication by transferring biomolecules, including proteins and RNA …

By inducing tumor-specific immune responses, tumor vaccines have recently aroused great
research interest. Herein, we design a targeted nanovaccine by equipping cell membrane …

Exosomes are nano vesicles from the larger family named Extracellular Vesicle (EV) s which
are released by various cells including tumor cells, mast cells, dendritic cells, B lymphocytes …

To develop RNA-based therapeutics, it is crucial to create delivery vectors that transport the
RNA molecule into the cell cytoplasm. Naturally released exosomes vesicles (also called …

Extracellular vesicles (EVs) have been proved a promising small interfering RNA (siRNA)
delivery vehicle to mediate gene‐silencing. Tumour‐derived extracellular vesicles (TDEVs) …

Exosome-like vesicles (ELVs) play an important role in intercellular communication by acting
as natural carriers for biomolecule transfer between cells. This unique feature rationalizes …